Herbert L Bonkovsky Selected Research

zinc mesoporphyrin

5/2010	Zinc mesoporphyrin induces rapid proteasomal degradation of hepatitis C nonstructural 5A protein in human hepatoma cells.
3/2008	Zinc mesoporphyrin induces rapid and marked degradation of the transcription factor Bach1 and up-regulates HO-1.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Herbert L Bonkovsky Research Topics

Disease

46	Fibrosis (Cirrhosis) 01/2019 - 12/2002
39	Hepatitis C 01/2019 - 04/2004
37	Chronic Hepatitis C 01/2019 - 12/2002
27	Liver Diseases (Liver Disease) 06/2015 - 02/2002
21	Chemical and Drug Induced Liver Injury 04/2022 - 01/2009
20	Hepatocellular Carcinoma (Hepatoma) 06/2019 - 09/2005
18	Porphyrias (Porphyria) 01/2022 - 11/2004
17	Acute Intermittent Porphyria (Porphyria, Acute) 12/2020 - 01/2005
17	Infections 04/2015 - 12/2002
10	Hepatic Porphyrias (Hepatic Porphyria) 01/2022 - 01/2005
9	Hepatitis 12/2017 - 01/2002
8	Erythropoietic Protoporphyria 01/2021 - 02/2002
7	Liver Cirrhosis (Hepatic Cirrhosis) 01/2019 - 03/2005
6	Pain (Aches) 01/2022 - 03/2005
6	Porphyria Cutanea Tarda 01/2013 - 04/2002
6	Disease Progression 09/2012 - 10/2004
6	Iron Overload 07/2012 - 04/2002
5	Hereditary Coproporphyria (Coproporphyrinogen Oxidase Deficiency) 11/2019 - 01/2005
5	Variegate Porphyria (Protoporphyrinogen Oxidase Deficiency) 11/2019 - 01/2005
4	Neoplasms (Cancer) 11/2020 - 01/2011
4	Acute Liver Failure (Fulminant Hepatic Failure) 01/2019 - 11/2009
3	Non-alcoholic Fatty Liver Disease 09/2019 - 06/2003
3	Hyponatremia 09/2015 - 01/2005
3	Pancreatic Neoplasms (Pancreatic Cancer) 12/2013 - 01/2011
3	Chronic Hepatitis (Chronic Active Hepatitis) 08/2013 - 07/2010
3	Hemochromatosis (Bronze Diabetes) 07/2012 - 03/2005
3	Virus Diseases (Viral Diseases) 11/2010 - 02/2007
2	Jaundice (Icterus) 04/2022 - 07/2002
2	Weight Loss (Weight Reduction) 01/2022 - 09/2013
2	Body Weight (Weight, Body) 11/2020 - 01/2019
2	Fatty Liver 09/2019 - 08/2016
2	Type 2 Diabetes Mellitus (MODY) 09/2019 - 07/2002
2	Insulin Resistance 09/2019 - 06/2003
2	End Stage Liver Disease 01/2019 - 06/2003
2	Necrosis 01/2018 - 06/2013
2	Cholestasis 11/2017 - 01/2017
2	Hepatitis B 10/2014 - 03/2007
2	Hypergammaglobulinemia (Hyperimmunoglobulinemia) 05/2014 - 09/2006
2	Autoimmune Hepatitis 05/2014 - 09/2006
2	Ascites 05/2011 - 01/2010
2	Hemorrhage 05/2011 - 01/2010
2	Esophageal and Gastric Varices (Esophageal Varices) 02/2010 - 01/2009

Drug/Important Bio-Agent (IBA)

34	Antiviral Agents (Antivirals)IBA 03/2015 - 04/2004
27	Heme (Haem)IBA 01/2022 - 02/2002
25	Ribavirin (Virazole)FDA LinkGeneric 04/2012 - 04/2004
19	IronIBA 09/2019 - 01/2002
17	InterferonsIBA 02/2013 - 04/2004
11	Dyphylline (Diprophylline)FDA Link 01/2022 - 01/2009
11	Proteins (Proteins, Gene)FDA Link 01/2019 - 07/2006
9	RNA (Ribonucleic Acid)IBA 01/2019 - 04/2004
6	PorphobilinogenIBA 01/2022 - 07/2013
6	PorphyrinsIBA 01/2022 - 11/2004
6	Biomarkers (Surrogate Marker)IBA 01/2019 - 03/2008
6	MicroRNAs (MicroRNA)IBA 01/2017 - 11/2010
5	Hemin (Panhematin)FDA Link 01/2022 - 01/2005
5	givosiranIBA 01/2022 - 01/2019
5	Hydro-Lyases (Dehydratases)IBA 11/2019 - 01/2005
5	Messenger RNA (mRNA)IBA 01/2019 - 04/2002
5	protoporphyrin IXIBA 12/2015 - 12/2005
5	Heme Oxygenase-1IBA 10/2015 - 07/2006
4	AcidsIBA 01/2022 - 11/2005
4	Aminolevulinic Acid (Levulan)FDA Link 01/2022 - 11/2014
4	Acute Hepatic PorphyriaIBA 01/2022 - 01/2020
4	Transaminases (Aminotransferases)IBA 11/2020 - 07/2002
4	AlbuminsIBA 01/2017 - 02/2002
4	peginterferon alfa-2a (Pegasys)FDA Link 12/2008 - 04/2004
3	TeaIBA 01/2022 - 11/2009
3	Ferrochelatase (Heme Synthetase)IBA 01/2021 - 02/2002
3	Hydroxymethylbilane Synthase (Porphobilinogen Deaminase)IBA 11/2019 - 11/2019
3	CytokinesIBA 01/2019 - 01/2013
3	EnzymesIBA 10/2017 - 02/2002
3	BilirubinIBA 12/2015 - 03/2007
3	AntioxidantsIBA 12/2015 - 03/2009
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 08/2014 - 09/2006
3	Cytidine Triphosphate (CTP)IBA 08/2011 - 10/2010
3	SilymarinIBA 04/2011 - 02/2008
3	Ferritins (Ferritin)IBA 11/2010 - 03/2005
3	DNA (Deoxyribonucleic Acid)IBA 11/2009 - 02/2007
2	Pharmaceutical PreparationsIBA 01/2022 - 12/2017
2	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2017 - 05/2014
2	afamelanotideIBA 01/2016 - 07/2015
2	HepcidinsIBA 10/2015 - 07/2012
2	AutoantibodiesIBA 05/2014 - 11/2009
2	Antimalarials (Antimalarial Agents)IBA 07/2012 - 02/2007
2	CollagenIBA 07/2012 - 03/2008
2	Aspartate Aminotransferases (Aspartate Transaminase)IBA 10/2011 - 01/2010
2	Alanine Transaminase (SGPT)IBA 10/2011 - 01/2010
2	Estrogens (Estrogen)FDA Link 01/2011 - 02/2007
2	Ethanol (Ethyl Alcohol)IBA 01/2011 - 06/2008
2	Transferrin (beta 2 Transferrin)IBA 11/2010 - 03/2005
2	Tissue Inhibitor of Metalloproteinase-1IBA 10/2010 - 03/2008
2	zinc mesoporphyrinIBA 05/2010 - 03/2008
2	alpha-Fetoproteins (alpha-Fetoprotein)IBA 02/2010 - 09/2005
2	Alkaline PhosphataseIBA 01/2009 - 07/2002
2	Neutralizing AntibodiesIBA 04/2006 - 03/2005
2	Glucose (Dextrose)FDA LinkGeneric 03/2005 - 01/2005
1	Lamotrigine (Lamictal)FDA LinkGeneric 04/2022

Therapy/Procedure

40	Therapeutics 01/2022 - 09/2002
12	Liver Transplantation 01/2022 - 02/2002
3	Retreatment 01/2007 - 11/2006